Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.7383
-0.0195 (-2.57%)
At close: Mar 28, 2025, 4:00 PM
0.7561
+0.0178 (2.41%)
After-hours: Mar 28, 2025, 7:41 PM EDT

Nektar Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
98.4390.1292.06101.91152.92
Upgrade
Revenue Growth (YoY)
9.21%-2.10%-9.67%-33.36%33.41%
Upgrade
Cost of Revenue
30.6933.7721.6424.919.48
Upgrade
Gross Profit
67.7456.3570.4277.01133.44
Upgrade
Selling, General & Admin
76.7577.4292.33122.84104.68
Upgrade
Research & Development
120.91114.16218.32400.27408.68
Upgrade
Operating Expenses
197.66191.58310.66523.11513.36
Upgrade
Operating Income
-129.92-135.23-240.24-446.1-379.92
Upgrade
Interest Expense
-28.11-25.33-28.91-47.31-37.12
Upgrade
Interest & Investment Income
14.519.016.782.7318.28
Upgrade
Other Non Operating Income (Expenses)
-0.39-1.1533.31-8.19-
Upgrade
EBT Excluding Unusual Items
-143.92-142.7-229.05-498.87-398.76
Upgrade
Merger & Restructuring Charges
-15.67-51.96-135.93--
Upgrade
Impairment of Goodwill
--76.5---
Upgrade
Gain (Loss) on Sale of Assets
40.39-5.1---
Upgrade
Other Unusual Items
----24.41-45.19
Upgrade
Pretax Income
-119.2-276.26-364.98-523.28-443.95
Upgrade
Income Tax Expense
-0.24-0.23.220.560.49
Upgrade
Net Income
-118.96-276.06-368.2-523.84-444.44
Upgrade
Net Income to Common
-118.96-276.06-368.2-523.84-444.44
Upgrade
Shares Outstanding (Basic)
206190187183179
Upgrade
Shares Outstanding (Diluted)
206190187183179
Upgrade
Shares Change (YoY)
8.24%1.53%2.10%2.64%2.05%
Upgrade
EPS (Basic)
-0.58-1.45-1.97-2.86-2.49
Upgrade
EPS (Diluted)
-0.58-1.45-1.97-2.86-2.49
Upgrade
Free Cash Flow
-177.18-193.47-309.68-427.65-320.55
Upgrade
Free Cash Flow Per Share
-0.86-1.02-1.66-2.33-1.79
Upgrade
Gross Margin
68.82%62.53%76.50%75.57%87.26%
Upgrade
Operating Margin
-131.99%-150.05%-260.97%-437.76%-248.45%
Upgrade
Profit Margin
-120.86%-306.31%-399.98%-514.03%-290.64%
Upgrade
Free Cash Flow Margin
-180.01%-214.68%-336.41%-419.65%-209.62%
Upgrade
EBITDA
-125.53-127.41-227.21-431.96-365.74
Upgrade
EBITDA Margin
-127.53%-141.38%-246.81%--239.18%
Upgrade
D&A For EBITDA
4.397.8213.0314.1514.18
Upgrade
EBIT
-129.92-135.23-240.24-446.1-379.92
Upgrade
EBIT Margin
-131.99%-150.05%-260.97%--248.45%
Upgrade
Revenue as Reported
98.4390.1292.06101.91152.92
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q